HENRY FORD HEALTH SYSTEM

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1915-01-01

Employees: 5K

Market Cap: -

Website: http://www.henryford.com

Clinical Trials

Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke

Phase 1

Terminated

Conditions: Ischemic Stroke

Interventions: Drug: Sildenafil (Viagra)
Other: Usual care

First Posted Date: 2007-03-27

Last Posted Date: 2011-03-16

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 20

Registration Number: NCT00452582

Locations: 🇺🇸
Henry Ford Hospital, Detroit, Michigan, United States

Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer

Phase 2

Terminated

Conditions: Head and Neck Cancer
Carcinoma, Squamous Cell

First Posted Date: 2007-03-16

Last Posted Date: 2010-02-02

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 6

Registration Number: NCT00448240

Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma

Phase 1

Terminated

Conditions: Pancreatic Cancer

Interventions: Genetic: Ad5-yCD/mutTKSR39rep-ADP

First Posted Date: 2006-12-25

Last Posted Date: 2011-06-23

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 8

Registration Number: NCT00415454

Locations: 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States

Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo

Not Applicable

Completed

Conditions: Vitiligo

First Posted Date: 2006-08-22

Last Posted Date: 2024-04-30

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 17

Registration Number: NCT00367224

Locations: 🇺🇸
Department of Dermatology/Henry Ford Hospital, Detroit, Michigan, United States

Pregabalin for Abdominal Pain From Adhesions

Phase 4

Terminated

Conditions: Abdominal Pain
Surgical Adhesions

Interventions: Drug: Pregabalin 75 or 150 mg BID for 7 weeks followed by open label pregabalin 150 mg BID for 4 weeks
Drug: Placebo first followed by open label pregabalin

First Posted Date: 2006-04-04

Last Posted Date: 2023-10-23

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 18

Registration Number: NCT00310765

Locations: 🇺🇸
Henry Ford Health System, West Bloomfield, Michigan, United States

Antibiotic Lock Solutions in the Prevention of Catheter Related Bacteremia

Phase 4

Completed

Conditions: ESRD

First Posted Date: 2006-02-22

Last Posted Date: 2006-02-22

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 120

Registration Number: NCT00294502

Locations: 🇺🇸
Henry Ford Hospital, Detroit, Michigan, United States

Randomized Trial of Iontophoresis Versus Injection of Corticosteroids for Lateral Epicondylitis

Phase 3

Completed

Conditions: Lateral Epicondylitis
Work Related Injury

First Posted Date: 2005-11-23

Last Posted Date: 2007-04-27

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 80

Registration Number: NCT00257634

Locations: 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States

Tailored Asthma Management for Urban Teens

Not Applicable

Completed

Conditions: Asthma

Interventions: Behavioral: Generic web-based asthma education
Behavioral: Tailored Web-based Asthma Management

First Posted Date: 2005-09-20

Last Posted Date: 2012-12-20

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 450

Registration Number: NCT00201058

Locations: 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States

Changes in Physician Performance Through Continuous Professional Development

Not Applicable

Completed

Conditions: Asthma
Health Personnel

First Posted Date: 2005-06-22

Last Posted Date: 2009-02-13

Lead Sponsor: Henry Ford Health System

Target Recruit Count: 40

Registration Number: NCT00115284

Locations: 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy